Table 3.
Family | Protein | Gene | Mutation-Related Diseases | IBD-Associated | Function | Complex |
---|---|---|---|---|---|---|
NLR | MHC class II transactivator | CIITA | Bare lymphocyte syndrome RA |
Unknown | Positive regulator of class II MHC | |
NLRB | NRL family apoptosis inhibitory protein | NAIP | Spinal muscular atrophy | Unknown | Anti-apoptotic (inhibits CASP3, CASP7 and CASP9) | Sensor component of NLRC4 that recognizes and binds CprI from pathogenic bacteria C. violaceum |
NLRC | NOD1 | NOD1 | IBD, Asthma, Behcet’s disease and sarcoidosis | Yes | Innate and adaptive immune responses and cellular homeostasis. Binds bacterial peptidoglycans, single-stranded RNA (ssRNA) from viruses and the metabolite sphingosine-1-phosphate |
Interacts with RIPK2 activating NF-kB and MAPK signaling pathways |
NLRC | NOD2 | NOD2 | Crohn’s disease and Blau syndrome | Yes | Innate and adaptive immune responses and cellular homeostasis. Binds LPS by recognizing the muramyl dipeptide (MDP), single-stranded RNA (ssRNA) from viruses and the metabolite sphingosine-1-phosphate |
Interacts with RIPK2 activating NF-kB and MAPK signaling pathways. Interacts with NLRP1 leading to IL-1 release. Interacts with ATG16L1 leading to autophagy |
NLRC | NOD-like receptor caspase recruitment domain containing proteins 3–5 | NLRC3 | Yes | Negative regulator of the innate immune response (negative regulation of NF-kB and type I interferon signaling pathways) | Prevents NLRP3 inflammasome formation and may affect NOD1- or NOD2-mediated NF-kB activation | |
NRLC4 | FCAS 4 Autoinflammation with infantile enterocolitis |
Yes | Innate immune response. Promotes caspase-1 activation, cytokine production and macrophage pyroptosis |
Homo-oligomerizes in the NLRC4 inflammasome and enters the NRLP3 inflammasome |
||
NRLC5 | Pityriasis rubra pilaris Bare lymphocytic syndrome type I FMF |
Unknown | Negative regulator of the innate immune response (negative regulation of NF-kB and type I interferon signaling pathways) | |||
NLRP | NACHT, LRR, and PRD containing proteins 1–14 | NLRP1-14 | NRLP1: VAMAS1 MSPC JRRP |
Yes | NLRP1: Innate immunity and inflammation. Cytokines IL-1, IL-18 and gasdermin-D (GSDMD), leading to pyroptosis, an inflammatory form of programmed cell death |
NRLP1 inflammasome response to various pathogen-associated signals, recruits pro-caspase-1 (proCASP1) and promotes caspase-1 (CASP1) activation; may be activated by MDP in a NOD2-dependent manner |
NRLP3: FCAS1 AIADK MWS CINCA syndrome |
Yes | NLRP3: regulation of inflammation, immune response, and apoptosis. Stimulated by extracellular ATP, reactive oxygen species, K(+) efflux, crystals of monosodium urate or cholesterol, amyloid-beta fibers, environmental or industrial particles and nanoparticles, cytosolic dsRNA | NRLP3 inflammasome upstream activator of NF-kappaB signaling | |||
NLRP12: FCAS2 |
Yes | NLRP12 potent mitigator of inflammation Primarily expressed in dendritic cells and macrophages, inhibits both canonical and non-canonical NF-kB and ERK activation pathways Functions as a negative regulator of NOD2 by targeting it to degradation via the proteasome pathway. Promotes bacterial tolerance |
||||
NLRX | NOD-like receptor with “unknown” domain | NLRX1 | Histiocytic sarcoma Combined oxidative phosphorylation deficiency 4 Mooren Ulcer Mitochondrial Complex V Nuclear deficiency Type 3 |
Unknown | Regulator of mitochondrial antivirus responses. Promotes autophagy Enhances NF-kB and JUN N-terminal kinase dependent signaling through the production of reactive oxygen species. Regulates energy metabolism in a sex-dependent manner |
Regulates NLRP3 inflammasome activation to attenuate apoptosis |
Data from GeneCard®, The human gene database–https://www.genecards.org/ (accessed on 25 January 2023).